Weight change during pharmacological blockade of interleukin-6 or tumor necrosis factor-α in patients with inflammatory rheumatic disorders: A 16-week comparative study-Reference-Cited by-同舟云学术

Weight change during pharmacological blockade of interleukin-6 or tumor necrosis factor-α in patients with inflammatory rheumatic disorders: A 16-week comparative study

Published:2013-02 Issue:2 Volume:61 Page:353-355
ISSN:1043-4666
Container-title:Cytokine
language:en
Short-container-title:Cytokine

Author:

Younis Said,Rosner Itzhak,Rimar Doron,Boulman Nina,Rozenbaum Michael,Odeh Majed,Slobodin Gleb

Publisher

Elsevier BV

Subject

Molecular Biology,Hematology,Biochemistry,Immunology,Immunology and Allergy

Reference10 articles.

1. Tocilizumab for the treatment of rheumatoid arthritis;Tanaka;Expert Rev Clin Immunol,2010

2. Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: Results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structu

3. Clinical safety of tocilizumab in rheumatoid arthritis;Bannwarth;Expert Opin Drug Saf,2011

4. Interleukin-6-defficient mice develop mature-onset obesity;Wallenius;Nat Med,2002

5. Body mass index (BMI), BMI change and mortality in community-dwelling seniors without dementia;Keller;J Nutr Health Aging,2005

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in metabolic parameters and serum YKL-40 levels in Chinese rheumatoid arthritis patients during tocilizumab therapy;Clinical Rheumatology;2024-05-02

2. Colorable role of interleukin (IL)-6 in obesity hypertension: A hint from a Chinese adult case-control study;Cytokine;2023-08

3. Practical management of patients on anti-IL6R therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI);Joint Bone Spine;2021-06

4. Body composition in patients with early rheumatoid arthritis;Rheumatology Science and Practice;2021-03-03

5. Roles of inflammation in intrinsic pathophysiology and antipsychotic drug-induced metabolic disturbances of schizophrenia;Behavioural Brain Research;2021-03